The TRANSPERS Program on Evidence and Reimbursement for Precision Medicine is based on a conceptual framework of Stakeholders, Topics, and Mechanisms & Capabilities as shown in the figure.

Payer Approach Diagram

The program has two components:

  1. Systematic Evidence Reviews of Payer Coverage Policies: TRANSPERS Payer Coverage Policy Registry contains coverage, reimbursement and policy decisions by payers.
  2. Understanding Payer Decision-Making: TRANSPERS Payer Advisory Board, established in 2007, is comprised of private payers and thought leaders.

In addition, TRANSPERS Director Kathryn Phillips is the chair of the ​Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (GEECS).

Learn more about our work

Subscribe to our newsletter by emailing [email protected].